Epibulbar rosai-dorfman disease: novel manifestation and treatment.
暂无分享,去创建一个
D. Chu | L. Bielory | N. Mirani | Y. Tu | Avni A. Shah
[1] L. Kritharides,et al. Cyclosporin A and atherosclerosis--cellular pathways in atherogenesis. , 2010, Pharmacology & therapeutics.
[2] J. Rootman,et al. The Spectrum of Orbital Rosai-Dorfman Disease , 2006, Ophthalmic plastic and reconstructive surgery.
[3] J. Rosai,et al. Immunophenotypic characterization of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). , 1990, Seminars in diagnostic pathology.
[4] J. Rosai,et al. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. , 1990, Seminars in diagnostic pathology.
[5] Komp Dm. The treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). , 1990 .
[6] D. Komp. The treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). , 1990, Seminars in diagnostic pathology.
[7] J. Rosai,et al. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. , 1969, Archives of pathology.